This trial is testing a new potential treatment for people diagnosed with Alzheimer's disease. We want to see if it's safe, tolerable, and can help with memory and cognition problems.
By joining this trial you may help improve our understanding of Alzheimer’s Disease to benefit patients in the future. There is also potential for improvement in cognitive Alzheimer’s Disease symptoms while taking the new potential treatment. Things like your travel to the site will be paid for, and we can even organise this for you. You'll also have access to close medical monitoring and a team that really care.
You will be part of this trial for up to 50 weeks. During the treatment period (36 weeks), you'll take a pill every morning. It can be taken with or without food, whatever works best for you. You will either get the trial pill or a placebo, which is a pill that looks like the trial treatment but doesn't have any medicine in it. You will be closely monitored, with 11 visits during the trial period (which includes a couple of phone calls).
Alzheimer's disease is a progressive neurological disorder that affects the brain. It leads to cognitive decline, memory loss, and emotional changes, impacting on the indidivdual as well as family and caregivers.
This trial is all about finding out if a daily pill can help people with Alzheimer's disease. We want to see if this pill is safe, if people can tolerate it well, and if it actually works to improve the symptoms of Alzheimer's disease.
Have cognition and memory issues due to Alzheimer's disease
Be 50 years or older
Be any gender
Actinogen Medical (ACW) is a pioneering biotechnology company dedicated to advancing a cutting-edge therapy targeting neurological disorders linked to chronically elevated brain cortisol levels. Actinogen are committed to reshaping the landscape of neurological care and improving patients' lives.